Dual-Channel Catheter Imaging Brings Multiplexed Biology Into the Vessel Wall
High-risk atherosclerotic plaque is defined by more than luminal narrowing or surface irregularity. Its danger lies in the biology hidden inside the vessel wall: calcification, inflammatory cell infiltration, osteogenic activity, and other molecular processes that can destabilize a lesion long before a clinical event occurs. A catheter that can map both structure and biology in one pass has long been the goal, but single-target approaches leave much of that complexity unseen.
This study presents a dual-channel near-infrared fluorescence system integrated with optical coherence tomography in a catheter platform designed for intravascular use. The engineering problem was straightforward to state and hard to solve: multiplexed fluorescence imaging inside a blood-filled artery invites spectral crosstalk, and crosstalk blurs the meaning of the signal. By using temporally modulated excitation synchronized to the OCT trigger, the investigators created two fluorescence excitation signals separated by a half-cycle phase difference, allowing simultaneous detection of two molecular targets without the channel contamination that undermines conventional multiplexed designs.
One channel tracked calcified regions linked to osteogenic activity. The other targeted mannose receptor-expressing cells, including a specific macrophage subset.
Temporal Modulation Solved the Crosstalk Problem
The core technical advance was not simply adding a second fluorophore. It was the timing architecture. Time-interleaved excitation, locked to the OCT trigger, generated two distinct NIRF excitation signals that could be separated during acquisition rather than disentangled afterward. In practical terms, this reduces the risk that one molecular signature spills into the other and produces a misleading readout in a plaque that is already biologically heterogeneous.
Phantom experiments verified crosstalk-free detection of the two channels. That matters because vessel wall imaging is only as useful as the specificity of the signal. If calcification and inflammatory-cell staining leak into the same emission channel, the resulting image may look sophisticated while telling the clinician very little about the underlying biology. By preserving channel separation, the platform moves closer to the kind of molecular precision that intravascular imaging has promised but not consistently delivered.
Rabbit Atherosclerosis Revealed Two Distinct Plaque Signatures
In vivo testing in a rabbit model of atherosclerosis showed that the catheter could visualize two molecular processes at once within OCT-defined plaque structures. One probe, ALN-PEG-Cy5.5, was used to identify calcified areas associated with osteogenic activity. The second, MMR-PEG-Cy7, marked mannose receptor-expressing cells, including a macrophage subset relevant to plaque inflammation. The value of this pairing is biological as much as technical: calcification and macrophage activity often coexist within vulnerable lesions, but they do not represent the same pathology and do not imply the same therapeutic target.
The OCT component supplied the anatomic frame. NIRF then layered molecular information onto that frame, allowing the same plaque to be read as both structure and active disease process. Ex vivo fluorescence imaging and immunohistochemistry supported the relevance of each channel, linking the optical signals to the expected tissue biology.
A single marker can miss the point in atherosclerosis.
Why Multiplexed Plaque Imaging Could Change Intravascular Assessment
Current intravascular imaging often forces a trade-off between morphology and mechanism. OCT is excellent for resolving plaque architecture, fibrous cap features, and other fine structural details, but it does not by itself identify the molecular activity driving progression. Fluorescence imaging can reveal biology, yet single-target systems may reduce a layered disease process to a single dimension. A calcified plaque with active inflammatory signaling is not the same lesion as a heavily mineralized but biologically quiet one.
By pairing two molecular markers with OCT in a single catheter, this platform offers a more complete view of plaque pathobiology. That could be especially useful in lesions where calcification, inflammatory recruitment, and osteogenic remodeling overlap. The biological logic is compelling: plaque rupture risk emerges from interacting mechanisms, not from a lone biomarker, and imaging tools that can sample several of those mechanisms simultaneously may better reflect real disease behavior.
The study also suggests a path around a long-standing technical bottleneck in multiplexed intravascular imaging. Spectral overlap has limited the field because traditional fluorescence systems struggle to maintain channel fidelity in a compact catheter environment. Temporal modulation sidesteps part of that problem by separating signals in time rather than depending only on spectral separation. For a clinical platform that must operate inside a narrow vascular lumen, that design choice is not a minor technical detail; it is the feature that makes multiplexing plausible.
What the Platform Does Well, and What Still Needs Proof
The data establish feasibility in phantoms, then extend that feasibility into an animal model with biologically relevant plaque targets. They do not establish clinical performance in humans, event prediction, or decision-making benefit. No patient outcomes were measured, and no comparison against invasive or noninvasive clinical standards was presented in the supplied material. The work sits squarely in the translational space between imaging physics and bedside utility.
Even so, the implications are concrete. A catheter that can identify calcified regions and mannose receptor-expressing cells in the same lesion could eventually help distinguish plaques that are merely anatomically advanced from plaques that are actively evolving. In coronary disease, that distinction has always mattered because surface anatomy alone does not capture the inflammatory and mineralizing forces that turn a lesion unstable.
The next barrier is not signal generation. It is proof of utility in human vessels, where motion, blood attenuation, lesion complexity, and procedural constraints will all test whether the dual-channel approach retains its clarity outside the laboratory and rabbit model. Until then, the study stands as a technically credible step toward intravascular imaging that can read plaque biology with greater than single-marker resolution.